Review Article
The Effect and Safety of 5-HT1F Receptor Agonist Lasmiditan on Migraine: A Systematic Review and Meta-Analysis
Figure 3
Forest plot: responder rate for pain freedom at 2 h of lasmiditan versus placebo after the first dose (50 mg, 100 mg, and 200 mg).